Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in BRAFV600E Colorectal Cancer.

Hazar-Rethinam M, Kleyman M, Han GC, Liu D, Ahronian LG, Shahzade HA, Chen L, Parikh AR, Allen JN, Clark JW, Kwak EL, Faris JE, Murphy JE, Hong TS, Van Seventer EE, Nadres B, Hong CB, Gurski JM Jr, Jessop NA, Dias-Santagata D, Iafrate AJ, Van Allen EM, Corcoran RB.

Cancer Discov. 2018 Apr;8(4):417-427. doi: 10.1158/2159-8290.CD-17-1227. Epub 2018 Feb 5.

PMID:
29431697
2.

Selecting the most appropriate time points to profile in high-throughput studies.

Kleyman M, Sefer E, Nicola T, Espinoza C, Chhabra D, Hagood JS, Kaminski N, Ambalavanan N, Bar-Joseph Z.

Elife. 2017 Jan 26;6. pii: e18541. doi: 10.7554/eLife.18541.

3.

Tradeoffs between Dense and Replicate Sampling Strategies for High-Throughput Time Series Experiments.

Sefer E, Kleyman M, Bar-Joseph Z.

Cell Syst. 2016 Jul;3(1):35-42. doi: 10.1016/j.cels.2016.06.007. Epub 2016 Jul 21.

4.

B Cells Promote Pancreatic Tumorigenesis.

Roghanian A, Fraser C, Kleyman M, Chen J.

Cancer Discov. 2016 Mar;6(3):230-2. doi: 10.1158/2159-8290.CD-16-0100.

5.

STAG2 promotes error correction in mitosis by regulating kinetochore-microtubule attachments.

Kleyman M, Kabeche L, Compton DA.

J Cell Sci. 2014 Oct 1;127(Pt 19):4225-33. doi: 10.1242/jcs.151613. Epub 2014 Jul 29.

6.

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients.

Kuntzen T, Timm J, Berical A, Lennon N, Berlin AM, Young SK, Lee B, Heckerman D, Carlson J, Reyor LL, Kleyman M, McMahon CM, Birch C, Schulze Zur Wiesch J, Ledlie T, Koehrsen M, Kodira C, Roberts AD, Lauer GM, Rosen HR, Bihl F, Cerny A, Spengler U, Liu Z, Kim AY, Xing Y, Schneidewind A, Madey MA, Fleckenstein JF, Park VM, Galagan JE, Nusbaum C, Walker BD, Lake-Bakaar GV, Daar ES, Jacobson IM, Gomperts ED, Edlin BR, Donfield SM, Chung RT, Talal AH, Marion T, Birren BW, Henn MR, Allen TM.

Hepatology. 2008 Dec;48(6):1769-78. doi: 10.1002/hep.22549.

7.

A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection.

Boulet S, Kleyman M, Kim JY, Kamya P, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF.

AIDS. 2008 Jul 31;22(12):1487-91. doi: 10.1097/QAD.0b013e3282ffde7e.

PMID:
18614872
8.

Low perforin and elevated SHIP-1 expression is associated with functional anergy of natural killer cells in chronic HIV-1 infection.

Alter G, Suscovich TJ, Kleyman M, Teigen N, Streeck H, Zaman MT, Meier A, Altfeld M.

AIDS. 2006 Jul 13;20(11):1549-51.

PMID:
16847410

Supplemental Content

Loading ...
Support Center